Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
1.293
+0.043 (3.45%)
At close: Apr 1, 2025, 4:00 PM
1.310
+0.017 (1.31%)
After-hours: Apr 1, 2025, 4:21 PM EDT
Mustang Bio Employees
Mustang Bio had 80 employees as of December 31, 2023. The number of employees decreased by 33 or -29.20% compared to the previous year.
Employees
80
Change (1Y)
-33
Growth (1Y)
-29.20%
Revenue / Employee
n/a
Profits / Employee
-$196,900
Market Cap
3.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MBIO News
- 26 days ago - Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement - GlobeNewsWire
- 4 weeks ago - Mustang Bio Announces Sale of Fixed Assets and Exit of Facility - GlobeNewsWire
- 6 weeks ago - Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 7 weeks ago - Mustang Bio Announces Closing of $8 Million Public Offering - GlobeNewsWire
- 7 weeks ago - Mustang Bio Announces Pricing of $8 Million Public Offering - GlobeNewsWire
- 2 months ago - Mustang Bio Announces Reverse Stock Split - GlobeNewsWire
- 5 months ago - Mustang Bio Receives Positive Listing Determination from Nasdaq - GlobeNewsWire
- 5 months ago - Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma - GlobeNewsWire